Alterations in ceramide content were likewise observed in an in vitro cellular model of CF mesenchymal stem cells (MSCs) represented by control human lung MSCs, where CFTR activity is blocked using a specific CFTR inhibitor (inh172). The gene discussed is CFTR; the disease is cystic fibrosis.